FIL1L (FILIP1L)
(Filamin A Interacting Protein 1-Like (FILIP1L))
Protein Region
Middle Region
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-FILIP1L antibody (Catalog #: ARP52360_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
FIL1L (FILIP1L)
(Filamin A Interacting Protein 1-Like (FILIP1L))
Synonymes
DOC-1 Peptide, DOC1 Peptide, GIP130 Peptide, GIP130a Peptide, GIP130b Peptide, GIP130c Peptide, GIP90 Peptide, 4631422O05Rik Peptide, Doc1 Peptide, FILIP1L Peptide, filamin A interacting protein 1 like Peptide, filamin A interacting protein 1-like Peptide, FILIP1L Peptide, Filip1l Peptide, filip1l Peptide
Sujet
FILIP1L acts as a regulator of the antiangiogenic activity on endothelial cells. When overexpressed in endothelial cells, FILIP1L leads to inhibition of cell proliferation and migration and an increase in apoptosis. FILIP1L inhibits melanoma growth when e
Alias Symbols: DOC-1, DOC1, GIP90, GIP130, GIP130a, GIP130b, GIP130c